Developing solutions for neglected and underserved conditions. Key initiatives include:

• Snakebite Envenomation Solutions: A rapid point-of-care test (identifying krait/cobra/viper bites) and a region-specific polyvalent antivenom program.
• Camelid Antibody (Nanobody) Platform: Stable single-domain antibodies for snakebite therapy, affordable autoimmune treatments, low-cost cancer diagnostics, bone-regeneration biologics, and more.
• Human Hyperimmune Serum Production: Local manufacturing of pooled human plasma therapies (e.g. for rabies, Hepatitis B, tetanus, diphtheria).
• Therapeutic Bacteriophage Platform (AMR): Custom phage cocktails against multi-drug-resistant Gram-negative infections.

0 Comments